Triple
T5981347
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | EMERGE (Study 302) |
E133123
|
entity |
| Predicate | biomarkerAssessment |
P22710
|
FINISHED |
| Object | amyloid plaque levels in the brain |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: amyloid plaque levels in the brain | Statement: [EMERGE (Study 302), biomarkerAssessment, amyloid plaque levels in the brain]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: biomarkerAssessment Context triple: [EMERGE (Study 302), biomarkerAssessment, amyloid plaque levels in the brain]
-
A.
diagnosticBiomarker
chosen
Indicates that one entity serves as a measurable biological indicator used to detect, confirm, or help diagnose a condition or disease in another entity.
-
B.
hasPrognosticFactor
Indicates that something serves as a factor influencing or predicting the likely outcome or course of a condition, event, or situation.
-
C.
O1Biotype
Indicates that an entity has or is classified by a specific biological type or category.
-
D.
hasPreclinicalFeature
Indicates that an entity exhibits a characteristic, sign, or attribute that is present before the full clinical manifestation of a condition or disease.
-
E.
hasClinicalSignificance
Indicates that something (such as a finding, variant, or condition) has a meaningful impact or relevance in a clinical or medical context.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0086f45e8819098f73dd16d45ec9d |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c04a6921b081908a6f6323d5c7a062 |
completed | March 22, 2026, 8 p.m. |
| PD | Predicate disambiguation | batch_69c049de98648190962b14fd341c93da |
completed | March 22, 2026, 7:58 p.m. |
Created at: March 22, 2026, 4:04 p.m.